Avid Bioservices (CDMO)
(Delayed Data from NSDQ)
$9.45 USD
-0.05 (-0.53%)
Updated Jul 19, 2024 04:00 PM ET
After-Market: $9.44 -0.01 (-0.11%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth D Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
CDMO 9.45 -0.05(-0.53%)
Will CDMO be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for CDMO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CDMO
Avid Bioservices (CDMO) Reports Q2 Loss, Lags Revenue Estimates
Down -22.27% in 4 Weeks, Here's Why Avid Bioservices (CDMO) Looks Ripe for a Turnaround
CDMO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Twist Bioscience (TWST) Reports Q4 Loss, Tops Revenue Estimates
BioCardia (BCDA) Soars 168% on FDA Nod to Heart Failure Study
Avid Bioservices (CDMO) Moves 9.0% Higher: Will This Strength Last?
Other News for CDMO
Laughing Water Capital Q2 2024 Letter
Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2024
Asana, Clover Health Investments, Hertz Global And Other Big Stocks Moving Higher On Friday
Why Kaival Brands Innovations Shares Are Trading Lower By 47%? Here Are Other Stocks Moving In Friday's Mid-Day Session
How To Profitably Hedge With Put Options